These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3827939)
1. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue. Willmott N; Cummings J Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939 [TBL] [Abstract][Full Text] [Related]
2. Relationship between reductive drug metabolism in tumour tissue of anthracyclines in microspherical form and anti-tumour activity. Willmott N; Cummings J; Marley E; Smyth JF Biochem Pharmacol; 1990 Mar; 39(6):1055-62. PubMed ID: 2322293 [TBL] [Abstract][Full Text] [Related]
3. The consequences of doxorubicin quinone reduction in vivo in tumour tissue. Cummings J; Willmott N; Hoey BM; Marley ES; Smyth JF Biochem Pharmacol; 1992 Dec; 44(11):2165-74. PubMed ID: 1472081 [TBL] [Abstract][Full Text] [Related]
4. Comparison of albumin and casein microspheres as a carrier for doxorubicin. Chen Y; Willmott N; Anderson J; Florence AT J Pharm Pharmacol; 1987 Dec; 39(12):978-85. PubMed ID: 2894445 [TBL] [Abstract][Full Text] [Related]
5. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition. Cummings J; Willmott N; Marley E; Smyth J Biochem Pharmacol; 1991 Jun; 41(12):1849-54. PubMed ID: 2039540 [TBL] [Abstract][Full Text] [Related]
6. Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity. Implications for the drugs' in vivo mechanism of action. Cummings J; Allan L; Smyth JF Biochem Pharmacol; 1994 Apr; 47(8):1345-56. PubMed ID: 8185643 [TBL] [Abstract][Full Text] [Related]
7. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat. Gallo JM; Hung CT; Gupta PK; Perrier DG J Pharmacokinet Biopharm; 1989 Jun; 17(3):305-26. PubMed ID: 2810070 [TBL] [Abstract][Full Text] [Related]
8. Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues. Cummings J; Willmott N; More I; Kerr DJ; Morrison JG; Kaye SB Biochem Pharmacol; 1987 May; 36(9):1521-6. PubMed ID: 3579988 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. Almond BA; Hadba AR; Freeman ST; Cuevas BJ; York AM; Detrisac CJ; Goldberg EP J Control Release; 2003 Aug; 91(1-2):147-55. PubMed ID: 12932646 [TBL] [Abstract][Full Text] [Related]
10. Application of regression analysis in the evaluation of tumor response following the administration of adriamycin either as a solution or via albumin microspheres to the rat. Gupta PK; Hung CT; Lam FC J Pharm Sci; 1990 Jul; 79(7):634-7. PubMed ID: 2398473 [TBL] [Abstract][Full Text] [Related]
11. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration. Kerr DJ; Willmott N; McKillop JH; Cummings J; Lewi HJ; McArdle CS Cancer; 1988 Sep; 62(5):878-83. PubMed ID: 3409170 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. Gallo JM; Gupta PK; Hung CT; Perrier DG J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075 [TBL] [Abstract][Full Text] [Related]
14. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats. Gupta PK; Hung CT Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381 [TBL] [Abstract][Full Text] [Related]
15. Preparation of adriamycin magnetic albumin microspheres and their experimental antitumor effects in vitro and in vivo. Tao K; Chen D; Chen J; Tian Y; Wu Z; Wang X; Yang X J Tongji Med Univ; 1999; 19(4):295-9. PubMed ID: 12938522 [TBL] [Abstract][Full Text] [Related]
16. [Anti-tumor effects of adriamycin, 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on rat mammary cancer induced by 7,12-dimethyl benz (A) anthracene]. Tominaga T; Kitamura M; Yoshida Y; Kosaki G Gan To Kagaku Ryoho; 1984 Aug; 11(8):1663-8. PubMed ID: 6433800 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. Moritera T; Ogura Y; Yoshimura N; Honda Y; Wada R; Hyon SH; Ikada Y Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3125-30. PubMed ID: 1399416 [TBL] [Abstract][Full Text] [Related]
18. Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres. Jones C; Burton MA; Gray BN Br J Cancer; 1989 May; 59(5):743-5. PubMed ID: 2736208 [TBL] [Abstract][Full Text] [Related]
19. Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats. Gupta PK; Hung CT; Rao NS J Pharm Sci; 1989 Apr; 78(4):290-4. PubMed ID: 2724092 [TBL] [Abstract][Full Text] [Related]
20. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]